MIDAZOLEX 5, 15
Ampoule Midazolam 5, 15mg/ml ( 1, 3ml )
|Generic Name of Product||Brand Name||Dosage Form||Strength||Pharmacologic Group||Therapeutic Group||Unit Per Pack|
|Midazolam||Midazolex®||Ampoule||5 mg/ml (1ml) - 5 mg/ml (3ml)||Benzodiazepines||General anaesthesia||10|
Indications And Usage
For sedation by continuous infusion in patients in intensive care.
For the administration of Midazolam Injection, the patient should be placed in a supine position and remain there throughout the procedure. Resuscitation facilities should always be available and a second person fully trained in the use of such equipment should always be present.
Use of this drug for conscious sedation in patients with severe respiratory failure, or acute respiratory depression.
Special caution is required for the indication of conscious sedation in patients with impaired respiratory function
Sedation, amnesia, impaired attention and impaired muscular function may adversely affect the ability to drive or use machines.
Pregnancy and lactation
Midazolam passes in low quantities into breast milk. Nursing mothers should be advised to discontinue breast-feeding for 24 hours following administration of midazolam.
Renal and liver Impairment
There is no specific data in patients with severe renal impairment (creatinine clearance below 30 ml/min) receiving midazolam for induction of anaesthesia.